VRTX - Company ID 0000875320
The table below shows VERTEX PHARMACEUTICALS INC / MA's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $4.98B | $6.14B | $5.49B | $4.94B | $4.97B | $4.67B |
| Short-term investments | $1.32B | $1.71B | $1.75B | $1.35B | $1.41B | $1.53B |
| Receivables | $2.31B | $2.13B | $2.00B | $1.95B | $1.89B | $1.81B |
| Inventory | $2.25B | $1.77B | $1.77B | $1.63B | $1.50B | $1.36B |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $11.69B |
| $12.54B |
| $11.73B |
| $10.57B |
| $10.43B |
| $10.01B |
| Property, plant & equipment | - | - | - | - | - | - |
| Goodwill | $2.42B | $1.09B | $1.09B | $1.09B | $1.09B | $1.09B |
| Total assets | $32.74B | $27.42B | $26.48B | $24.86B | $24.04B | $22.88B |
| Accounts payable | $472.60M | $429.50M | $489.30M | $420.30M | $442.30M | $445.00M |
| Total current liabilities | $5.00B | $3.94B | $3.88B | $4.48B | $4.14B | $3.78B |
| Long-term debt | $3.50B | - | - | - | - | - |
| Total liabilities | $11.83B | $7.18B | $7.12B | $7.54B | $6.86B | $6.38B |
| Retained earnings | $16.34B | $15.69B | $14.59B | $12.37B | $11.29B | $10.25B |
| Total equity | $20.91B | $20.25B | $19.36B | $17.32B | $17.18B | $16.50B |